Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Angelopoulos J et al. – Ezetimibe coadministered with statins is effective in reducing LDL–C in patients who do not attain target LDL–C levels while on statin monotherapy. Simultaneous administration of a statin plus ezetimibe regimen in patients who are treatment–naI¨ve is also efficient at reducing plasma LDL–C.

Related Articles

Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia
Journal of Cardiovascular Pharmacology and Therapeutics, 11/12/09    Relevance Score: 87%

Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
Lipids in Health and Disease, 10/13/09    Relevance Score: 87%

Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09    Relevance Score: 84%

Abbott Statement on ARBITER 6 - HALTS Results and Abbotts Niaspan
Abbott, 11/16/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address